Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAMLETT antipsychotic continuation versus dose reduction/discontinuation after first-episode psychosis remission
NL-OMON55504Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2017
- Countries
- 1
01
Overview
Randomised, single-blind trial in Schizophrenia Spectrum Disorders (SSD) and schizophrenia (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Long-term social recovery. Started Sep 2017; status: recruiting.
02
Conditions
Schizophrenia Spectrum Disorders (SSD)schizophrenia
Beyond the preview
Go deeper on NL-OMON55504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55504.